Search for: "In Re XENCOR, INC. "
Results 1 - 5
of 5
Sort by Relevance
|
Sort by Date
17 May 2024, 9:37 pm
” In re Xencor, Inc., No. 2023-2048 (Fed. [read post]
3 Apr 2024, 9:13 am
by Dennis Crouch On January 23, 2024, the Federal Circuit granted the USPTO’s request for a remand in the case of In re Xencor, Inc. [read post]
23 Jan 2024, 8:01 am
In re Xencor, 23-2048 (Fed. [read post]
4 Dec 2023, 5:39 am
In the pending Federal Circuit appeal In re Xencor, the USPTO Director recently filed an opposed motion asking the Court to remand the case back to the PTAB. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]